Two weeks ago, a couple came to the pediatric surgery clinic at Qilu Hospital of Shandong University (Qingdao) with their baby in their arms; it turned out that there was a hemangioma growing on the left side of the child’s face, and the tumor occupied a large area of the child’s face in front of the left ear. Since this kind of hemangioma is a hemangioma affecting the face, current surgical and laser treatments can leave large scars or pigment loss, and the results are poor. After evaluating the child’s physical condition, Director of Pediatric Surgery Lei Zhang decided to apply the latest international treatment plan of oral propranolol (Takeaway). It is reported that the international oral propranolol method for the treatment of hemangioma was discovered in 2008, and its application in China is still relatively small, and due to the characteristics of the drug itself and the fact that infants tolerate the drug differently than adults, the drug is still less used in infant hemangioma, but Shandong University Qilu Hospital has started to apply the therapy in the treatment of heavy and facial hemangioma affecting infants 3 years ago, and has not only achieved good It has not only achieved good curative effect, but also accumulated a lot of valuable clinical experience. After the child took propranolol orally for 3 days, the family was pleased to find that the color of the tumor started to turn from bright red to darker and lighter. After returning to the hospital for review, Director Zhang Lei modified the treatment dosage and continued the oral medication for 2-3 months before reviewing again. According to Director Zhang Lei, oral propranolol is quite effective for this type of hemangioma, and the treatment period varies from 3 months to 1.5 years depending on the size and type of hemangioma. Hemangioma is a common disease in pediatric surgery. Due to the location and pathological typing of hemangioma, there are various treatment methods, mainly conservative observation, surgical excision, tumor injection, laser treatment, ozone treatment, etc. Different treatment methods have their own indications and defects; however, there is still a lack of effective treatment options for heavy hemangioma and large hemangioma involving the face; since the discovery in 2008 Since the discovery of the role of propranolol in the treatment of hemangioma in 2008, several large international hospitals have conducted in-depth research on the optimal therapeutic dose of this drug; at present, the Department of Pediatric Surgery of Qilu Hospital of Shandong University has applied this treatment plan to dozens of children, and has accumulated a lot of clinical experience while continuously adjusting the drug dose, and has achieved good clinical results.